Heather Miller
Principal Analyst, Revenue Management
Expertise:
Heather Miller joined EVERSANA in 2024 as a Principal Analyst, bringing nearly a decade of specialized experience in pharmaceutical pricing strategy and compliance. Prior to joining EVERSANA, Heather spent eight years working with multiple pharmaceutical manufacturers, where she cultivated a deep expertise in government pricing programs, including Medicaid Drug Rebate Program (MDRP), 340B, Federal Supply Schedule (FSS), and Veterans Affairs (VA) contracting.
Throughout her career, Heather has led cross-functional initiatives to ensure regulatory compliance, optimize pricing operations, and support strategic decision-making across commercial and government channels. Her work has included managing complex audits, implementing pricing system enhancements, and advising on policy changes that impact manufacturer obligations under CMS and VA guidelines.
Heather holds an MBA in Healthcare Administration from Eastern University, where she focused on the intersection of policy, economics, and patient access. She earned her Bachelor of Arts from Penn State University, and continues to stay engaged with industry developments through ongoing education and professional networks.
Known for her analytical rigor and collaborative leadership style, Heather is passionate about helping life sciences companies navigate the evolving landscape of government pricing with integrity and precision.
Articles by Heather Miller
The Most-Favored-Nation Model: Global Benchmark or Global Risk?
In response to growing public concern over rising drug costs, U.S. policymakers have proposed a Most-Favored-Nation (MFN) pricing model, linking domestic drug prices to those negotiated in other developed countries, many of which operate under tightly regulated single-payer systems. While the MFN model is framed as a cost-saving solution, its ripple effects could be far-reaching. […]